Exane Derivatives’s Brookfield BN Stock Holding History

Exane Derivatives’s Portfolio BN Stock Details BN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$44	Hold	2	–	–	﹤0.01%	741
2022 Q1	$57	Hold	2	–	–	﹤0.01%	1000
2021 Q4	$60	Hold	2	–	–	﹤0.01%	866
2021 Q3	$54	Hold	2	–	–	﹤0.01%	1032
2021 Q2	$50	Hold	2	–	–	﹤0.01%	1036
2021 Q1	$44	Hold	2	–	–	﹤0.01%	870
2020 Q4	$41	Sell	2 -23,825	-100%	-$477K	﹤0.01%	815
2020 Q3	$422K	Hold	23,827	–	–	0.12%	149
2020 Q2	$420K	Sell	23,827 -344	-1%	-$6.05K	0.11%	161
2020 Q1	$382K	Sell	24,171 -4,055	-14%	-$83.4K	0.11%	142
2019 Q4	$611K	Buy	+28,226	New	+$563K	0.11%	148

Other funds holding BN

Brookfield Corp Toronto, Ontario, Canada $77B AUM 10.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Exane Derivatives's BN Position: Q2 2022 in Review

Exane Derivatives held its Brookfield (BN) position steady in Q2 2022 at 2 shares worth $44. The position accounts for ﹤0.01% of the portfolio, ranked #741.

Exane Derivatives first reported a position in BN in Q4 2019 and has held it in 11 quarters since. The position peaked at $611K in Q4 2019. 716 funds tracked by Wall St. Rank hold BN as of Q2 2022.

Exane Derivatives held 2 shares of Brookfield worth $44 as of Q2 2022.
Exane Derivatives left its Brookfield share count unchanged in Q2 2022.
Brookfield made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #741 holding.
Exane Derivatives first reported a position in Brookfield in Q4 2019 and has held it in 11 quarters since.
Exane Derivatives's Brookfield position peaked at $611K in Q4 2019.
716 funds tracked by Wall St. Rank held Brookfield as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.